Guidelines from various medical societies differ in their recommendations. Their inherent biases offer an explanation:
The preventive medicine group and the generalist groups worry more about costs and complications which follow the screening strategy. The urologists and cancer experts worry more about curing cancer. By implication, they worry less about the collateral damage which comes from screening.
